Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Learn what to include in your crypto portfolio to maximize returns. Make informed choices for a balanced investment.
23,861 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
As markets rally into mid-2026, analysts spotlight five stock setups where Wall Street sees the most upside, driven b...
A July data center power surge is lifting select U.S.-listed industrials. Here’s a fresh look at the stocks riding th...
Investors are weighing whether UTES's AI-driven utility tilt justifies a roughly 0.50% fee as 2026 market conditions ...
As Berkshire transitions to Greg Abel, Warren Buffett’s final investment points to a return to era-defining brands. T...
IBM's shares sank as Anthropic's Claude Code intensifies AI competition, pushing ibm’s stock heads worst for a month ...
A rumored $111 billion Paramount Warner Bros' deal could fuse studios, streaming, and networks under a private group,...
Bank of America reinstates Ford with a Buy rating and a $17 target, while Rivian is downgraded to Underperform with a...
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
U.S. equities climbed on Friday as top performing stocks led a broad rally, with technology and energy names pushing ...
Three growth-focused ETFs have fallen this month as rates move and leadership shifts unsettle risk assets. One fund s...